(HealthDay News) — Genetic tests can show which patients with the blood cancer multiple myeloma should respond to targeted ...

Doctors at AIIMS, Delhi are in the process of developing a low cost antibody-based adaptive cellular therapy for treatment of ...

Doctors at AIIMS, Delhi are in the process of developing a low-cost antibody-based adaptive cellular therapy for treatment of ...

The Johnson & Johnson drug Darzalex showed promise in helping keep a precancerous condition from progressing to the blood ...

A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition ...

1 At present, the FDA has approved elranatamab for patients with multiple myeloma who are relapsed/refractory after at least ...

In separate, live events, Binod Dhakal, MD, MS; and Laahn H. Foster, MD, polled oncologists on therapeutic options for a ...

Singh explained. Cancer cells proliferate at a very rapid pace which deprive normal cells of nutrients resulting in cancer ...

After a bone marrow biopsy and blood tests, he was diagnosed with a rare, incurable cancer called multiple myeloma, which affects a type of white blood cell, called plasma cells, that play a key ...

and prednisone in people with newly diagnosed multiple myeloma who cannot receive a type of stem cell transplant that uses their own stem cells (autologous stem cell transplant) · in combination ...

In smoldering multiple myeloma, patients have high levels of abnormal plasma cells and elevated levels of monoclonal protein in the blood. Hear executives from Quantum Health, Surescripts ...

Ciltacabtagene autoleucel achieved a 100% complete response rate in patients with high-risk smoldering multiple myeloma, as ...